Sudarshan Pharma Industries to Acquire 9.5% Stake in US-Based MedTherapy Biotech
Mumbai (Maharashtra) [India], September 7: BSE-listed Sudarshan Pharma Industries Ltd [BSE Scrip Code: 543828, Trading Symbol: SUDARSHAN, ISIN: INE00TV01023] has announced its first major overseas biotech acquisition. In a disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company informed exchanges that its Board of Directors at its meeting held today –…
Read More “Sudarshan Pharma Industries to Acquire 9.5% Stake in US-Based MedTherapy Biotech” »
